Advanced regenerative solutions in diabetic foot ulcer therapy: delivery of mesenchymal stem cells in injectable hydrogels
Engineered hydrogels deliver cell-derived healing factors directly into diabetic wounds, a promising approach still moving toward human testing.
This review synthesizes current evidence on injectable hydrogel-based delivery systems for MSC-derived exosomes in diabetic foot ulcer treatment, highlighting their potential to overcome limitations of cell-based therapies through improved exosome protection and sustained localized release. The approach is promising but remains largely preclinical, with clinical translation dependent on standardization of exosome production and regulatory approval pathways.
What the study was
- Study design
- Narrative review
- Population
- Diabetic patients with foot ulcers
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Stem Cell Research & Therapy
Why it surfaced
Review of regenerative medicine approach for DFU; out-of-watchlist but flagged as unsolicited find; addresses significant unmet need in diabetes complications but evidence is primarily preclinical.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.